229 related articles for article (PubMed ID: 24549270)
41. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
42. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial.
Navali N; Gassemzadeh A; Farzadi L; Abdollahi S; Nouri M; Hamdi K; Mallah F; Jalilvand F
Hum Reprod; 2016 Nov; 31(11):2520-2526. PubMed ID: 27680029
[TBL] [Abstract][Full Text] [Related]
43. Characteristics of progesterone changes in women with subtle progesterone rise in recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist cycle.
Seow KM; Lin YH; Hsieh BC; Huang LW; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
Gynecol Obstet Invest; 2010; 70(1):64-8. PubMed ID: 20203521
[TBL] [Abstract][Full Text] [Related]
44. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels.
Orvieto R; Nahum R; Meltzer S; Liberty G; Anteby EY; Zohav E
Gynecol Endocrinol; 2013 Sep; 29(9):843-5. PubMed ID: 23802563
[TBL] [Abstract][Full Text] [Related]
45. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
46. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
[TBL] [Abstract][Full Text] [Related]
47. Effect of BMI on the value of serum progesterone to predict clinical pregnancy outcome in IVF/ICSI cycles: a retrospective cohort study.
Shen Z; Luo X; Xu J; Jiang Y; Chen W; Yang Q; Sun Y
Front Endocrinol (Lausanne); 2023; 14():1162302. PubMed ID: 37152959
[TBL] [Abstract][Full Text] [Related]
48. Serum progesterone level above 0.85 ng/mL and progesterone/estradiol ratio may be useful predictors for replacing cleavage-stage with blastocyst-stage embryo transfer in fresh IVF/ICSI cycles without premature progesterone elevation.
Tokgoz VY; Tekin AB
Arch Gynecol Obstet; 2022 Apr; 305(4):1011-1019. PubMed ID: 34716819
[TBL] [Abstract][Full Text] [Related]
49. Serum progesterone concentration on day of HCG administration and IVF outcome.
Li R; Qiao J; Wang L; Zhen X; Lu Y
Reprod Biomed Online; 2008 May; 16(5):627-31. PubMed ID: 18492365
[TBL] [Abstract][Full Text] [Related]
50. [GnRH agonist triggering in IVF and luteal phase support in women at risk of ovarian hyperstimulation syndrome].
Guivarc'h-Levêque A; Jaffré F; Homer L; Moy L; Priou G; Colleu D; Denis I; Arvis P
Gynecol Obstet Fertil; 2013 Sep; 41(9):511-4. PubMed ID: 23972925
[TBL] [Abstract][Full Text] [Related]
51. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
[TBL] [Abstract][Full Text] [Related]
52. Serum GDF-8 levels change dynamically during controlled ovarian hyperstimulation in patients undergoing IVF/ICSI-ET.
Fang L; Yu Y; Zhang R; He J; Sun YP
Sci Rep; 2016 Jun; 6():28036. PubMed ID: 27329327
[TBL] [Abstract][Full Text] [Related]
53. The impact of an increased progesterone-to-follicle number ratio on live delivery rates in women with normal ovarian reserve.
Chen Y; Ma L; Wang S
Int J Gynaecol Obstet; 2017 Oct; 139(1):84-89. PubMed ID: 28685817
[TBL] [Abstract][Full Text] [Related]
54. Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles.
Vanni VS; Somigliana E; Reschini M; Pagliardini L; Marotta E; Faulisi S; Paffoni A; Vigano' P; Vegetti W; Candiani M; Papaleo E
PLoS One; 2017; 12(5):e0176482. PubMed ID: 28520729
[TBL] [Abstract][Full Text] [Related]
55. High progesterone levels on the day of HCG administration do not affect the embryo quality and the reproductive outcomes of frozen embryo transfers.
Baldini D; Savoia MV; Sciancalepore AG; Malvasi A; Vizziello D; Beck R; Vizziello G
Clin Ter; 2018; 169(3):e91-e95. PubMed ID: 29938738
[TBL] [Abstract][Full Text] [Related]
56. Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer.
Bustillo M; Stern JJ; Coulam CB
Hum Reprod; 1995 Nov; 10(11):2862-7. PubMed ID: 8747033
[TBL] [Abstract][Full Text] [Related]
57. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
[TBL] [Abstract][Full Text] [Related]
58. Prediction of success in intracytoplasmic sperm injection (ICSI) by estimation of serum estradiol/progesterone ratio on the day of embryo transfer.
Rehman R; Hussain Z; Zuberi NA
J Pak Med Assoc; 2013 May; 63(5):609-13. PubMed ID: 23757990
[TBL] [Abstract][Full Text] [Related]
59. High progesterone levels on the day after HCG injection has no effect on clinical pregnancy outcomes in
Liang Z; Huang Q; Huang J; Wu J; Zeng D; Huang P
Front Endocrinol (Lausanne); 2024; 15():1372753. PubMed ID: 38689731
[TBL] [Abstract][Full Text] [Related]
60. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
